Avrobio Inc (NQ: AVRO )
1.110 +0.040 (+3.74%) Streaming Delayed Price Updated: 4:00 PM EDT, Jun 2, 2023 Add to My Watchlist
All News about Avrobio Inc
Recap: Avrobio Q1 Earnings
May 11, 2023
Avrobio Touts New Positive Data From Gaucher Disease Gene Therapy
December 07, 2022
Avrobio Inc (NASDAQ: AVRO) shares are trading higher after the company announced follow-up data demonstrating a durable treatment effect across key measures out to 36 months from a Phase 1/2 trial of...
Avrobio Touts Positive Data Gene Therapy Trial For Cystinosis, Showing Treatment Durability Of Up To 36 Months
May 18, 2023
Avrobio Inc (NASDAQ: AVRO) announced follow-up data demonstrating a durable treatment effect across key measures out to 36 months from a Phase 1/2 trial of an investigational gene therapy for...
AVROBIO Announces Leadership Transition
May 01, 2023
12 Health Care Stocks Moving In Thursday's Intraday Session
March 23, 2023
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 10, 2023
AVROBIO Announces Clinical Data For Gaucher Disease Gene Therapy; Says 'Following positive feedback from FDA and MHRA, registrational, global Phase 2/3 clinical trial for GD3 planned for second half 2023'
December 07, 2022
New compelling clinical data from first-ever Gaucher disease type 3 (GD3) patient and four Gaucher disease type 1 (GD1) patients dosed with investigational AVR-RD-02 Data from first pediatric GD3...
AVROBIO to Share Comprehensive Gaucher Disease Program Update
November 17, 2022
AVROBIO Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 03, 2022
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following